/

Other

/

NS Pharma, Inc.

NS Pharma, Inc.

NS Pharma, Inc.

Verified Nov 2026

Other

·

United States flag

Paramus, New Jersey

·

Since 1999

NS Pharma, Inc. is a U.S. pharmaceutical subsidiary of Japan-based Nippon Shinyaku, founded in 1999 and headquartered in Paramus, New Jersey. With 100–200 employees and estimated revenue between $100–250 million, the company develops therapies for rare and incurable diseases across hematology, urology, gynecology, neurology, and inflammatory conditions. It brought Viltepso to market for Duchenne Muscular Dystrophy and pursues exon-skipping therapies and JAK1 inhibition platforms.

NS Pharma, Inc.

Verified Nov 2026

AT A GLANCE

Founded

1999

Headquarters

United States flag

Paramus, New Jersey

Employees

100-200

Ownership

NS Pharma, Inc. at a glance

Revenue

$100-250M

Est. band

Employees

100-200

Founded

1999

Headquarters

Paramus, New Jersey

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

NS Pharma, Inc. is a U.S. pharmaceutical subsidiary of Japan-based Nippon Shinyaku, founded in 1999 and headquartered in Paramus, New Jersey. With 100–200 employees and estimated revenue between $100–250 million, the company develops therapies for rare and incurable diseases across hematology, urology, gynecology, neurology, and inflammatory conditions. It brought Viltepso to market for Duchenne Muscular Dystrophy and pursues exon-skipping therapies and JAK1 inhibition platforms.

At a glance

Attribute

Detail

Founded

1999

Headquarters

Paramus, New Jersey

Employees

100-200

Revenue

$100-250M (estimated)

What NS Pharma, Inc. makes

The company specializes in orphan drug development, with recent focus on exon-skipping therapies for muscular dystrophy and JAK1 inhibition approaches for inflammatory diseases.

Latest developments

Facilities

NS Pharma, Inc. is headquartered in Paramus, New Jersey. Public sources also reference these locations:

Company details

NS Pharma operates as a subsidiary of Nippon Shinyaku and collaborates with academic institutions and biotechnology partners, including a sponsored research agreement with Boston Children's Hospital announced in June 2026. NS Pharma, Inc. was founded in 1999, has an estimated 100-200 employees, and is headquartered in Paramus, New Jersey.

Frequently asked questions

What does NS Pharma, Inc. do?

NS Pharma, Inc. is a U.S. pharmaceutical subsidiary of Japan-based Nippon Shinyaku, founded in 1999 and headquartered in Paramus, New Jersey. With 100–200 employees and estimated revenue between $100–250 million, the company develops therapies for rare and incurable diseases across hematology, urology, gynecology, neurology, and inflammatory conditions. It brought Viltepso to market for Duchenne Muscular Dystrophy and pursues exon-skipping therapies and JAK1 inhibition platforms.

Where is NS Pharma, Inc. headquartered?

NS Pharma, Inc. is headquartered in Paramus, New Jersey (140 East Ridgewood Avenue, Paramus, New Jersey, 07652).

When was NS Pharma, Inc. founded?

NS Pharma, Inc. was founded in 1999.

How big is NS Pharma, Inc.?

NS Pharma, Inc. has an estimated 100-200 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Paramus, New Jersey (HQ)Headquarters · United States
Paramus, New Jersey (HQ)140 East Ridgewood Avenue, Paramus, New Jersey, 07652, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.